SCHEMBL10151091

SCHEMBL10151091

CC(C)Oc1ccc(/C=C/C=O)c([C@@H](C)OC[C@H]2CO2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.34
MAPK1 P28482 1/20 0.34
ALDH1A3 P47895 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
IRAK4 Q9NWZ3 1/20 0.31
ALDH1A1 P00352 5/20 0.31
HPGD P15428 4/20 0.31
TSHR P16473 4/20 0.31
KDM4E B2RXH2 2/20 0.31
HSD17B10 Q99714 2/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
TP53 P04637 3/20 0.30
HIF1A Q16665 2/20 0.30
PKM P14618 2/20 0.30
ADCY1 Q08828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6798328 0.89 ALDH1A1 (0.35) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL10132917 0.83 TP53 (0.32) MAPTMAPK1ALDH1A1HPGDTSHR
SCHEMBL6742510 0.82 MGLL (0.40) MAPTMAPK1CYP3A4MGLL
SCHEMBL6742282 0.79 MAPT (0.33) MAPTMAPK1TP53PPARGMGLL
SCHEMBL13263802 0.79 MAPT (0.33) MAPTMAPK1TP53PPARGMGLL
SCHEMBL6741984 0.77 ALDH1A1 (0.35) MAPTMAPK1ALDH1A1HPGDTSHR
SCHEMBL13263935 0.77 ALDH1A1 (0.35) MAPTIRAK4ALDH1A1HPGDTSHR
SCHEMBL6798063 0.77 PKM (0.37) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL10165711 0.76 CDK4 (0.30) CDK4CCND1
SCHEMBL12203608 0.75 ALDH1A1 (0.33) MAPTALDH1A1HPGDTSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183272-B2 Indanyl compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-22 US disclosed
US-20110319359-A1 INDANYL COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319359-A1 INDANYL COMPOUNDS RYR2, ORAI1, CASR MAPT 1359/4885MAPK1 3096/4885ALDH1A3 3734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.